Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana.
| Revenue (TTM) | $4.89B |
| Gross Profit (TTM) | $2.69B |
| EBITDA | $970.00M |
| Operating Margin | 12.30% |
| Return on Equity | -3.77% |
| Return on Assets | 1.47% |
| Revenue/Share (TTM) | $9.84 |
| Book Value | $13.02 |
| Price-to-Book | 1.67 |
| Price-to-Sales (TTM) | 2.22 |
| EV/Revenue | 2.946 |
| EV/EBITDA | 19.72 |
| Quarterly Earnings Growth (YoY) | -15.40% |
| Quarterly Revenue Growth (YoY) | 14.90% |
| Shares Outstanding | $499.45M |
| Float | $494.85M |
| % Insiders | 1.19% |
| % Institutions | 111.48% |
Volatility is currently expanding